Duncan Gilbert

10PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPredictive and prognostic markersPharmacogenomicsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 31, 2025
Preferences between three options for androgen deprivation therapy: a focus group study.

Hannah L Rush, Sophie Merrick, John Marshall

|Jul 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.

Nicholas D James, Fiona C Ingleby, Noel W Clarke

|Jun 07, 2022
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.

Chris C Parker, Nicholas D James, Christopher D Brawley

|Apr 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).

Nicholas D James, Noel W Clarke, Adrian Cook

|Nov 10, 2021
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial.

Hannah L Rush, Laura Murphy, Alicia K Morgans

|May 11, 2021
Accessing routinely collected health data to improve clinical trials: recent experience of access.

Archie Macnair, Sharon B Love, Macey L Murray

Pageof 2

Frequent Collaborators

6 joint publications

Matthew Sydes

5 joint publications

Nick James

5 joint publications

Ruth E Langley

5 joint publications

Hannah Rush